REDWOOD CITY, Calif., July 05, 2016 (GLOBE NEWSWIRE) --
WHO: Biotricity, Inc. (OTCQB:BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote monitoring solutions, will be demonstrating its revolutionary IoT-connected medical device at Shape, an AT&T Tech Expo being held on July 15–16, 2016 at AT&T Park in San Francisco, CA.
WHAT: Pundits expect that IoT will likely start on the medical side, as there are enough dollars there for people to build in those features. Telecoms are ripe for tapping into this market, because consumers who use these medical-grade wearable devices would consume a great deal of data if they thought there was value. There is a tremendous opportunity for manufacturers to build a wearable with IoT technology as they too will become just like a mobile phone. As chips get smaller, wearables will stop trying to connect to the phone and instead will connect directly to the cloud through a built-in IoT and then push data back down to the phone. The process will be offered in a total package plan that a telecom would give a user and allow them to connect as many devices as they see fit while paying a flat fee.
WHY: IDC predicts the global market for the Internet of Things (IOT) will nearly triple, reaching $1.7 trillion by 2020. IoT has long been considered critical to wearable innovation yet, despite the all-encompassing connectivity capabilities, few have adopted the technology into today’s wearable devices.
WHERE: Biotricity will be available to discuss the company’s ground-breaking, clinical-grade remote biometric monitoring solutions in booth # 136 at Shape.
WHEN: Shape, an AT&T Tech Expo is being held on July 15–16, 2016 at AT&T Park, San Francisco, CA. Executives from Biotricity will be available to discuss their state-of-the-art technology while at the show by visiting them in booth, # 136.
About Biotricity Inc.
Biotricity is a modern medical technology company focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity’s R&D continues to focus on the preventative healthcare market, with a vision of putting health management into the hands of the individual. The company aims to support the self-management of critical and chronic conditions with the use of innovative solutions to ease the growing burden on the healthcare system. To learn more, visit www.biotricity.com.
Media Contacts McCoin & Smith Communications Inc. Chris McCoin, Chris@mccoinsmith.com, 508-429-5988 Richard Smith, email@example.com, 978-433-3304 Investor Relations: Michael Koehler Liolios Group, Inc. BTCY@liolios.com, 949-574-3860